FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula (I), in which X is O, having inhibitor properties β-lactamase, or its pharmaceutically acceptable salts, based pharmaceutical composition, preparing a β-lactamase inhibitor for treating a bacterial infection.
EFFECT: novel inhibitors of β-lactamases are disclosed.
4 cl, 7 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THIOPHENE COMPOUND, ITS PRODUCTION METHOD AND ITS PHARMACEUTICAL APPLICATION | 2017 |
|
RU2709473C1 |
| ALPHA- AND BETA-UNSATURATED AMIDE COMPOUND-A BENZOTRIAZOLE DERIVATIVE USED AS A TGF-ΒRI INHIBITOR | 2017 |
|
RU2737737C2 |
| METALLO-β-LACTAMASE INHIBITORS | 2006 |
|
RU2462450C2 |
| ORALLY ADMINISTERED COMBINATIONS OF BETA-LACTAM ANTIBIOTICS AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2020 |
|
RU2825281C1 |
| COMPOUND WHICH IS PRO-DRUG OF LANOSTEROL, AS WELL AS METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2018 |
|
RU2720677C1 |
| CONTAINING A SUBSTITUTE, WHICH IS BUTANE, IN THE HETEROCYCLIC RING A PYRIDONE DERIVATIVE FOR TREATING FIBROSIS AND INFLAMMATORY DISEASES | 2017 |
|
RU2738844C2 |
| BETA-LACTAMASE INHIBITORS | 2009 |
|
RU2445314C9 |
| DERIVATIVE WITH CONDENSED RING AS A RECEPTOR INHIBITOR | 2018 |
|
RU2748993C1 |
| CERTAIN PROTEIN KINASE INHIBITORS | 2017 |
|
RU2738837C2 |
| CDK4/6 INHIBITOR | 2017 |
|
RU2747311C2 |
